Clinical Prediction Models for Valvular Heart Disease

Author:

Wessler Benjamin S.12,Lundquist Christine M.1,Koethe Benjamin1,Park Jinny G.1,Brown Kristen1,Williamson Tatum1,Ajlan Muhammad1,Natto Zuhair3,Lutz Jennifer S.1,Paulus Jessica K.1,Kent David M.1

Affiliation:

1. Predictive Analytics and Comparative Effectiveness (PACE) Center Institute for Clinical Research and Health Policy Studies (ICRHPS) Tufts Medical Center Boston MA

2. Division of Cardiology Tufts Medical Center Boston MA

3. Department of Dental Public Health Faculty of Dentistry King Abdulaziz University Jeddah Saudi Arabia

Abstract

Background While many clinical prediction models ( CPM s) exist to guide valvular heart disease treatment decisions, the relative performance of these CPM s is largely unknown. We systematically describe the CPM s available for patients with valvular heart disease with specific attention to performance in external validations. Methods and Results A systematic review identified 49 CPM s for patients with valvular heart disease treated with surgery (n=34), percutaneous interventions (n=12), or no intervention (n=3). There were 204 external validations of these CPM s. Only 35 (71%) CPM s have been externally validated. Sixty‐five percent (n=133) of the external validations were performed on distantly related populations. There was substantial heterogeneity in model performance and a median percentage change in discrimination of −27.1% ( interquartile range , −49.4%–−5.7%). Nearly two‐thirds of validations (n=129) demonstrate at least a 10% relative decline in discrimination. Discriminatory performance of Euro SCORE II and Society of Thoracic Surgeons (2009) models (accounting for 73% of external validations) varied widely: Euro SCORE II validation c‐statistic range 0.50 to 0.95; Society of Thoracic Surgeons (2009) Models validation c‐statistic range 0.50 to 0.86. These models performed well when tested on related populations (median related validation c‐statistics: Euro SCORE II , 0.82 [0.76, 0.85]; Society of Thoracic Surgeons [2009], 0.72 [0.67, 0.79]). There remain few (n=9) external validations of transcatheter aortic valve replacement CPM s. Conclusions Many CPM s for patients with valvular heart disease have never been externally validated and isolated external validations appear insufficient to assess the trustworthiness of predictions. For surgical valve interventions, there are existing predictive models that perform reasonably well on related populations. For transcatheter aortic valve replacement (CPM s additional external validations are needed to broadly understand the trustworthiness of predictions.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3